Tag: Genmab
Biontech secures new cancer drug with deal worth millions
Biontech founder Ugur Sahin The company is currently also growing through acquisitions. (Photo: imago images/photothek) Frankfurt With one of its largest deals to date, Biontech is expanding its product development…
Biontech continues to expand cancer research with vaccine billions
Frankfurt The Mainz-based biotech company Biontech uses the financial strength from the still strong business with Covid vaccines to further expand its cancer and vaccine research. The quarterly figures presented…
Biontech wants to deliver customized Omicron booster in autumn
Frankfurt After a noticeable drop in sales in the second quarter, the Mainz-based biotech company Biontech expects demand for Covid vaccines to increase again in the fourth quarter of the…
Biontech wants to deliver customized Omicron boosters in the fall
Frankfurt After a noticeable drop in sales in the second quarter, the Mainz-based biotech company Biontech expects demand for Covid vaccines to increase again in the fourth quarter of the…
Favorable valuations beckon in Europe
Lindt & Sprüngli in Switzerland One of the top names in certain equity funds with a focus on Europe. (Photo: Bloomberg) Frankfurt The stock exchanges seem to be defying the…
Stock Exchange on November 10th: Eight Points To Consider For Investors Today
Investors today look to key inflation data and the Economic Ways’ Report. Many companies also present their figures. .source site
Stock Exchange on November 10th: Seven Points That Are Important For Investors Today
Investors today look to key inflation data and the Economic Ways’ Report. Many companies also present their figures. .source site